Open-angle glaucoma (OAG) is a chronic
and degenerative condition
that causes optic nerve damage and potential blindness. The objective
of this review is to provide a brief overview on OAG with emphasis
on the importance of prostaglandin analogues for eye care. Bimatoprost
(6) is an important prostaglandin analogue widely used
in several medications for the treatment of open-angle glaucoma. A
literary review of the various approaches reported for the synthesis
of bimatoprost (6) drug substance is presented. In addition,
the reported bimatoprost (6) synthetic routes are assessed
to identify strengths and weaknesses from a drug substance process
chemistry perspective. A summary of bimatoprost (6) synthetic
routes assessment is also provided based on drug substance quality,
process, and environmental considerations.